[1]HU XL, ZHAO HW, WU XY.The epidemic status of hepatitis B virus infection.[J].J Clin Hepatol, 2012, 28 (6) :413-416. (in Chinese) 胡晓丽, 赵宏伟, 吴晓岩.乙型肝炎病毒感染的流行现状[J].临床肝胆病杂志, 2012, 28 (6) :413-416.
|
[2]WANG XJ, ZHANG RZ, HU YS, et al.Study on the epidemic status of viral hepatitis in China[J].Dis Surveill, 2004, 19 (8) :290-293. (in Chinese) 王晓军, 张荣珍, 胡苑笙, 等.我国病毒性肝炎流行现状研究[J].疾病监测, 2004, 19 (8) :290-293.
|
[3]DING WJ.Analysis of epidemic situation in Shanghai city of Pudong New Area from 2001 to 2004, acute viral hepatitis[J].Sh J Prev Med, 2005, 17 (10) :473-474. (in Chinese) 丁王静.上海市浦东新区2001-2004年急性病毒性肝炎疫情分析[J].上海预防医学, 2005, 17 (10) :473-474.
|
[4]Chinese Society of Infection Diseases and Parasitology, Chinese Society of Hepatology, Chinese Medical Association.Prevention and treatment of viral hepatitis[J].Chin J Infect Dis, 2001, 19 (1) :54-62. (in Chinese) 中华医学会传染病与寄生虫病学分会, 肝病学分会.病毒性肝炎防治方案[J].中华传染病杂志, 2001, 19 (1) :54-62.
|
[5]HOU MC, WC JC, KUO BI, et al.Heterosexual transmission as the most common route of acute hepatitis B virus infection among adults in Taiwan the importance of extending vaccination to susceptible adults[J].J Infect Dis, 1993, 167 (4) :938-941.
|
[6]LIANG XS, WANG MB, LI CZ, et al.A high viral load are high risk factors of acute hepatitis B delayed recovery[J].Chin J Infect Dis, 2010, 28 (4) :222-225. (in Chinese) 梁雪松, 万谟彬, 李成忠, 等.高病毒载量是急性乙型肝炎恢复趋势延缓的高危因素[J].中华传染病杂志, 2010, 28 (4) :222-225.
|
[7]XIA GL.Hepatitis B vaccine prevention effect and genotypes of hepatitis B virus research[J].Chin J Epidemiol, 2002, 23 (3) :225-227. (in Chinese) 夏国良.乙型肝炎疫苗预防效果和乙型肝炎病毒基因分型研究[J].中华流行病学杂志, 2002, 23 (3) :225-227.
|
[8]XIE ZW.The changes of HBeAg level in hepatitis B antiviral treatment efficacy on[J].J Clin Hepatol, 2013, 29 (2) :150-152. (in Chinese) 谢志伟.乙型肝炎抗病毒治疗中HBeAg水平变化对疗效的影响[J].临床肝胆病杂志, 2013, 29 (2) :150-152.
|
[9]LI DL, MIU XH, MIAO QL, et al.Sporadic adult acute hepatitis B pathogen follow-up study[J].Chin J Infect Dis, 2009, 27 (9) :522-526. (in Chinese) 李东良, 缪晓辉, 苗千里, 等.散发性成人急性乙型肝炎病原学随访研究[J].中华传染病杂志, 2009, 27 (9) :522-526.
|
[10]SEEGER C, MASON WS.Hepatitis B virus biology[J].Microbiol Mol Biol Rev, 2000, 64 (1) :51-68.
|
[11]ZHU JH, WU XM.Clinical significance of hepatitis B serum HBV in patients with cccDNA[J].J Prac Med, 2013, 29 (3) :395-397. (in Chinese) 朱锦宏, 吴晓蔓.乙肝患者血清HBV cccDNA的临床意义[J].实用医学杂志, 2013, 29 (3) :395-397.
|
[12]LAPOSTOLLE BW, BOWDEN S, LOCARNINI S, et al.Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy[J].Gastroenterology, 2004, 126 (7) :1750-1758.
|
[13]YANG Y, YANG L.Study on the correlation between detection and replication of hepatitis B virus serum HBsAg quantification[J].J Prac Med, 2013, 29 (5) :686-687. (in Chinese) 杨阳, 杨龙.血清HBsAg定量检测与乙型肝炎病毒复制的相关性研究进展[J].实用医学杂志, 2013, 29 (5) :686-687.
|
[14] Chinese Society of Hepatology, Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline for prevention and treatment of chronic hepatitis B[J].J Clin Hepatol, 2006, 22 (1) :3-15. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南[J].临床肝胆病杂志, 2006, 22 (1) :3-15.
|